CompaniesKeystone Heart

Keystone Heart

defunct
About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

5

As Collaborator

0

Total Enrollment

659

By Phase

NA: 4

By Status

COMPLETED: 5
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Today
NCT01448421
NCT02073864
NCT02536196
Hover over trial bars to see details

Recent Trials

NCT02536196Lead Sponsor
The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation
NACompleted
478 participants
Started: Jun 30, 2016 · Completed: Jun 30, 2019
NCT02070731Lead Sponsor
DEFLECT III: A Prospective, Randomized Evaluation of the TriGuard™ HDH Embolic Deflection Device During TAVI
NACompleted
86 participants
Started: Feb 28, 2014 · Completed: Apr 30, 2015
NCT02073851Lead Sponsor
DEFLECT II: A Study to Evaluate the Safety and Performance of the TriGuard™HDH in Patients Undergoing TAVR
NACompleted
12 participants
Started: Jan 31, 2014 · Completed: Sep 30, 2014
NCT02073864Lead Sponsor
A Study to Evaluate the Neuro-embolic Consequences of TAVR
N/ACompleted
46 participants
Started: Nov 30, 2013 · Completed: Aug 31, 2015
NCT01448421Lead Sponsor
DEFLECT I: Keystone Heart Embolic Deflection Trial
NACompleted
37 participants
Started: Mar 31, 2012 · Completed: Jan 31, 2014
Related Companies
Venus Medtech
merged
Keystone Heart | Biotech Hunter | Biotech Hunter